Literature DB >> 14631884

Pilot study: access to fitness facility and exercise levels in olanzapine-treated patients.

Suzanne Archie1, Jane Hamilton Wilson, Shelley Osborne, Heather Hobbs, Jean McNiven.   

Abstract

BACKGROUND: Increasingly alarmed by the health risks (that is, weight gain, elevated lipids, and poor glucose tolerance) posed by novel antipsychotic medications, clinicians who treat schizophrenia are attempting to help patients improve lifestyle factors. Unfortunately, schizophrenia research has neglected exercise as a legitimate adjunctive treatment for schizophrenia.
OBJECTIVE: To assess the extent to which stable patients with schizophrenia would adhere to an exercise program if offered access to a fitness facility.
METHODS: Ten of 20 stable patients with schizophrenia or schizoaffective disorder who were treated with olanzapine for at least 4 weeks had the opportunity to receive access to a Young Men's Christian Association (YMCA) fitness facility, based on random allocation. The intervention included a free membership to the YMCA for 6 months, with access to all the fitness amenities and equipment. The mean dosage of olanzapine was 11.5 mg daily for the YMCA group.
RESULTS: Of the 10 subjects, 2 did not attend at all. One subject met criteria for full attendance for each of the 6 months and lost 15 Kg. Dropout rates were as follows: 90% at 6 months, 70% at 5 months, and 40% at 4 months. The main reason they gave for poor attendance was lack of motivation. The mean weight gain was 2 kg in the YMCA group.
CONCLUSION: Most subjects did not regularly exercise or attend. They cited poor motivation as the main reason. The subject who exercised regularly lost a significant amount of weight.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631884     DOI: 10.1177/070674370304800910

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  28 in total

Review 1.  The pro-cognitive mechanisms of physical exercise in people with schizophrenia.

Authors:  Joseph Firth; Jack Cotter; Rebekah Carney; Alison R Yung
Journal:  Br J Pharmacol       Date:  2017-04-20       Impact factor: 8.739

2.  Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia.

Authors:  Kimberly R Warren; M Patricia Ball; Stephanie Feldman; Fang Liu; Robert P McMahon; Deanna L Kelly
Journal:  Biol Res Nurs       Date:  2010-12-30       Impact factor: 2.522

Review 3.  Interventions to reduce weight gain in schizophrenia.

Authors:  G Faulkner; T Cohn; G Remington
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Effect of a motivational group intervention upon exercise self efficacy and outcome expectations for exercise in Schizophrenia Spectrum Disorders (SSDs).

Authors:  Lora Humphrey Beebe; Kathlene Smith; Renee Burk; Olivera Dessieux; Dawn Velligan; Abbas Tavakoli; Clif Tennison
Journal:  J Am Psychiatr Nurses Assoc       Date:  2010-04       Impact factor: 2.385

5.  Physical Exercise Keeps the Brain Connected: Biking Increases White Matter Integrity in Patients With Schizophrenia and Healthy Controls.

Authors:  Alena Svatkova; René C W Mandl; Thomas W Scheewe; Wiepke Cahn; René S Kahn; Hilleke E Hulshoff Pol
Journal:  Schizophr Bull       Date:  2015-03-31       Impact factor: 9.306

6.  Effectiveness of a psychosocial weight management program for individuals with schizophrenia.

Authors:  Noosha Niv; Amy N Cohen; Alison Hamilton; Christopher Reist; Alexander S Young
Journal:  J Behav Health Serv Res       Date:  2014-07       Impact factor: 1.505

Review 7.  Metabolic syndrome associated with schizophrenia and atypical antipsychotics.

Authors:  Mehrul Hasnain; Sonja K Fredrickson; W Victor R Vieweg; Anand K Pandurangi
Journal:  Curr Diab Rep       Date:  2010-06       Impact factor: 4.810

8.  Feasibility of the Walk, Address, Learn and Cue (WALC) Intervention for schizophrenia spectrum disorders.

Authors:  Lora Humphrey Beebe; Kathlene Smith
Journal:  Arch Psychiatr Nurs       Date:  2009-08-06       Impact factor: 2.218

9.  "We're not just sitting on the periphery": a staff perspective of physical activity in older adults with schizophrenia.

Authors:  Heather Leutwyler; Erin M Hubbard; Dilip V Jeste; Sophia Vinogradov
Journal:  Gerontologist       Date:  2012-08-30

10.  Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.

Authors:  David C Henderson; Xiaoduo Fan; Paul M Copeland; Bikash Sharma; Christina P Borba; Ryan Boxill; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
Journal:  J Clin Psychopharmacol       Date:  2009-04       Impact factor: 3.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.